NEWS
News Articles
Alpharetta biopharma company names board member as interim CEO
An Alpharetta company that is working on treatments for eye disease patients has named a member of its board of directors as interim CEO. George Lasezkay succeeds Daniel H. White as chief executive of Clearside Biomedical Inc. (NASDAQ: CLSD). White resigned as president, CEO and as a member of the Clearside board to pursue other…
Read More- « Previous
- 1
- …
- 115
- 116
- 117